JGC
J. Goldman & Co Portfolio holdings
AUM
$3.18B
1-Year Return
9.17%
This Quarter Return
+0.54%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$2.69B
AUM Growth
+$480M
(+22%)
Cap. Flow
+$470M
Cap. Flow
% of AUM
17.45%
Top 10 Holdings %
Top 10 Hldgs %
22.28%
Holding
488
New
148
Increased
67
Reduced
73
Closed
119
Top Buys
| 1 |
Constellation Brands
STZ
|
+$111M |
| 2 |
Electronic Arts
EA
|
+$48.3M |
| 3 |
Golar LNG
GLNG
|
+$44.3M |
| 4 |
Akamai
AKAM
|
+$42M |
| 5 |
Merck
MRK
|
+$38.4M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$62.7M |
| 2 |
Best Buy
BBY
|
+$59.6M |
| 3 |
TKO Group
TKO
|
+$54.5M |
| 4 |
Hasbro
HAS
|
+$47.1M |
| 5 |
Norfolk Southern
NSC
|
+$46.1M |
Sector Composition
| 1 | Consumer Discretionary | 22.29% |
| 2 | Technology | 17.7% |
| 3 | Industrials | 16.21% |
| 4 | Healthcare | 12.75% |
| 5 | Communication Services | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
CervoMed
CRVO
$87M
| $286K | 0.01% |
16,707
+3,207
| +24% | +$54.9K |
|
277
XPeng
XPEV
$19.7B
| $253K | 0.01% |
+34,500
| New | +$253K |
|
278
Vera Therapeutics
VERA
$1.6B
| $246K | 0.01% |
6,800
-23,381
| -77% | -$846K |
|
279
SPDR S&P Bank ETF
KBE
$1.55B
| $244K | 0.01% |
+5,250
| New | +$244K |
|
280
Janux Therapeutics
JANX
$1.43B
| $226K | 0.01% |
+5,400
| New | +$226K |
|
|
SGI
281
Somnigroup International Inc.
SGI
$17.7B
| $221K | 0.01% |
+4,666
| New | +$221K |
|
282
Teva Pharmaceuticals
TEVA
$22.6B
| $219K | 0.01% |
13,500
-13,500
| -50% | -$219K |
|
283
Vaxcyte
PCVX
$4.25B
| $204K | 0.01% |
+2,700
| New | +$204K |
|
284
Geron
GERN
$868M
| $172K | ﹤0.01% |
40,500
-220,897
| -85% | -$937K |
|
285
Sally Beauty Holdings
SBH
$1.45B
| $161K | ﹤0.01% |
+15,047
| New | +$161K |
|
286
Larimar Therapeutics
LRMR
$331M
| $143K | ﹤0.01% |
19,705
-8,295
| -30% | -$60.1K |
|
287
American Airlines Group
AAL
$8.42B
| $138K | ﹤0.01% |
+12,209
| New | +$138K |
|
288
Bitdeer Technologies
BTDR
$2.96B
| $115K | ﹤0.01% |
+11,250
| New | +$115K |
|
289
Achieve Life Sciences
ACHV
$159M
| $115K | ﹤0.01% |
24,548
| – | – |
|
290
Veru
VERU
$50.8M
| $114K | ﹤0.01% |
13,500
-124,545
| -90% | -$1.05M |
|
|
WW
291
DELISTED
WW International
WW
| $77K | ﹤0.01% |
65,792
+48,692
| +285% | +$57K |
|
292
CalciMedica
CALC
$50M
| $74.8K | ﹤0.01% |
+18,900
| New | +$74.8K |
|
293
fuboTV
FUBO
$1.4B
| $62.4K | ﹤0.01% |
+50,321
| New | +$62.4K |
|
294
Savara
SVRA
$660M
| $52.4K | ﹤0.01% |
+13,000
| New | +$52.4K |
|
295
TherapeuticsMD
TXMD
$12.5M
| $21.8K | ﹤0.01% |
13,562
| – | – |
|
296
Krystal Biotech
KRYS
$4.09B
| – | – |
-20,963
| Closed | -$3.73M |
|
297
LCI Industries
LCII
$2.51B
| – | – |
-3,373
| Closed | -$415K |
|
298
Eli Lilly
LLY
$673B
| – | – |
-3,059
| Closed | -$2.38M |
|
299
Light & Wonder
LNW
$7.39B
| – | – |
0
| – | – |
|
300
Match Group
MTCH
$9.19B
| – | – |
-32,040
| Closed | -$1.16M |
|